Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KAPA | Kairos Pharma, LTD. | CEO and Chairman, Director, 10%+ Owner | $7.69M | +$5.76K | +0.07% | Nov 20, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|